
Reset all filters
01 8Bereskin & Parr LLP
Reset all filters
01 42570873
02 42781431
Reset all filters
01 8INFIGRATINIB
Reset all filters
01 8CAPSULE
Reset all filters
01 42025-06-23
02 42030-12-06
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Brand Name : TRUSELTIQ
Patent Number : 2570873
Filing Date : 2005-06-23
Strength per Unit : 50 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Brand Name : TRUSELTIQ
Patent Number : 2781431
Filing Date : 2010-12-06
Strength per Unit : 50 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Brand Name : TRUSELTIQ
Patent Number : 2570873
Filing Date : 2005-06-23
Strength per Unit : 75 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Brand Name : TRUSELTIQ
Patent Number : 2781431
Filing Date : 2010-12-06
Strength per Unit : 75 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Brand Name : TRUSELTIQ
Patent Number : 2570873
Filing Date : 2005-06-23
Strength per Unit : 100 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Brand Name : TRUSELTIQ
Patent Number : 2781431
Filing Date : 2010-12-06
Strength per Unit : 100 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Brand Name : TRUSELTIQ
Patent Number : 2570873
Filing Date : 2005-06-23
Strength per Unit : 125 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-06-23
Date Granted : 2014-04-29
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Brand Name : TRUSELTIQ
Patent Number : 2781431
Filing Date : 2010-12-06
Strength per Unit : 125 mg / dose
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-12-06
Date Granted : 2017-10-31
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF